BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Art Pappas will speak about future trends in biotechnology at the Charlotte Biotechnology Conference in Charlotte, NC
News | 10. 27. 2010
